Options
Options Articles
We’ve already covered the reasons behind the monumental share price drop being seen at VeriFone (NYSE:PAY). But what is interesting is that it really looks like the options traders must have...
Published:
Last Updated:
Stock options are supposed to be an incentive for doing well. They are priced the day of the grant. If the share price goes up, they have value and can be sold. If the share price goes down, they...
Published:
We were screening options activity today and something came up that where bets had significantly grown from our prior coverage. Earlier this year we covered some strange biotech options activity...
Published:
Last Updated:
These are the unofficial market closes, and note how close the DJIA is to 14,000 again……. DJIA 13,820.84; +54.14 (+0.39%)S&P500 1,525.56; +6.81 (+0.45%)NASDAQ ...
Published:
Last Updated:
VMware’s (NYSE:VMW) stock options trading has been almost as exciting and puzzling as watching the stock in this post-IPO frenzy since EMC Corp. (NYSE:EMC) launched its partial spin-off in last...
Published:
Last Updated:
Business Week noted Arena Pharmaceuticals Inc. (NASDAQ:ARNA) as one of its three "Inside Wall Street" weekly stock picks this morning, and frankly it was the only pick with any sizzle to it. Arena...
Published:
Last Updated:
EMC Corp. (NYSE:EMC) and VMware Inc. (NYSE:VMW) announced early this morning that the exchange offer for certain employee stock options is being extended to 11 AM EST on August 13, 2007. The prior...
Published:
Everyone knows how to make a bet on a stock going higher. Most know how to make bets against a stock ("Sell the News") with short selling or buying put options. But there are ways to leverage the...
Published:
It is always interesting seeing option and share sale activity of company executives and insiders, particularly ahead of a stock split and particularly if your employee shares and options are in a...
Published:
Last Updated:
Dendreon (DNDN) has seen a lot of the old hyperactive trading volume come out of the stock now that it is post-FDA panel review and post-ASCO. The stock has barely traded 2 million shares so far...
Published:
If you thought the day would never come that Dendreon (DNDN-NASDAQ) would see its volatility, its hyperactive volume, and its options premium compress to something back to almost normal, guess again:...
Published:
Last Updated:
Dendreon (DNDN-NASDAQ) has only up to 4 full trading before that May 15 FDA review date. The funny thing here is that the options have actually become more expensive since reporting on this last...
Published:
A.G.Edwards has initiated the recently volatile and controversial Dendreon (DNDN-NASDAQ) with a Hold/Speculative rating. The summary points are that it is starting the biotech as a Hold rated stock...
Published:
Last Updated:
It wasn’t all that long ago that we were dicussing the implosion of the CBOE Volatility Index (the VIX) as it was trying to suck its way to under 10.0 for the first time since the mid-1990’s. ...
Published:
Last Updated:
Dendreon’s short interest actually grew again in April from 26.4 million shares in March to 33.9 million shares. The short interest was listed as 16.8 million shares in February. That is almost...
Published:
Last Updated: